Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
Twelve hospitals across India will be part of the network which will support the trial in India
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
Subscribe To Our Newsletter & Stay Updated